pravastatin has been researched along with ADPKD in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baliga, MM; Cadnapaphornchai, MA; Chonchol, M; Christians, U; Gitomer, BY; Hopp, K; Klawitter, J | 1 |
| Cadnapaphornchai, MA; George, DM; Gitomer, B; McFann, K; Schrier, RW; Strain, JD; Wang, W | 1 |
| Cadnapaphornchai, MA | 1 |
| Cadnapaphornchai, MA; Christians, U; Gitomer, B; Klawitter, J; McFann, K; Pennington, AT; Schrier, RW; Wang, W | 1 |
| Coombes, JS; Fairley, KF; Fassett, RG; Kincaid-Smith, P; Packham, D | 1 |
| Cadnapaphornchai, MA; George, DM; Masoumi, A; McFann, K; Schrier, RW; Strain, JD | 1 |
1 review(s) available for pravastatin and ADPKD
| Article | Year |
|---|---|
Autosomal dominant polycystic kidney disease in children.
Topics: Blood Pressure; Child; Child, Preschool; Diet, Sodium-Restricted; Disease Progression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Polycystic Kidney, Autosomal Dominant; Pravastatin; Prognosis; Renal Dialysis; Ultrasonography | 2015 |
4 trial(s) available for pravastatin and ADPKD
| Article | Year |
|---|---|
Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
Topics: Adolescent; Albuminuria; Child; Creatinine; Double-Blind Method; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Magnetic Resonance Imaging; Organ Size; Polycystic Kidney, Autosomal Dominant; Pravastatin; Young Adult | 2014 |
Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adolescent; Biomarkers; Child; Female; Humans; Hydroxyeicosatetraenoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linoleic Acids; Male; Organ Size; Oxidative Stress; Polycystic Kidney, Autosomal Dominant; Pravastatin; Time Factors; Young Adult | 2015 |
Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease.
Topics: Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Pravastatin; Prospective Studies; Proteinuria | 2010 |
Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.
Topics: Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Child; Disease Progression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Kidney; Lisinopril; Male; Polycystic Kidney, Autosomal Dominant; Pravastatin; Renin-Angiotensin System; Young Adult | 2011 |
1 other study(ies) available for pravastatin and ADPKD
| Article | Year |
|---|---|
Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease.
Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Cross-Sectional Studies; Female; Humans; Male; Metabolome; Metabolomics; Polycystic Kidney, Autosomal Dominant; Pravastatin; Treatment Outcome; Young Adult | 2021 |